Study with 18 total overnights

8425-693 Part B Cohort 3 Part B Cohort 3

Back To Current Studies

Study with 18 total overnights

Study Number

8425-693 Part B Cohort 3


Part B Cohort 3




18 - 55


Daytona Beach, Florida



Study Dates

Dec. 06 - 30, 2022

Additional Information

The purpose of this part of the study is to evaluate the safety, tolerability (side effects), how much of the study drug gets into the bloodstream and urine, and how long it takes the body to get rid of it. This study will also assess the effect of multiple oral doses of the study drug on glycolic acid (a naturally occurring substance found in foods) levels in blood and urine.  You will receive an oral dose of the study drug or a placebo (inactive drug) once daily for 14 days. Each group will receive a higher dose than the previous group.
Labcorp Daytona Beach, FL is recruiting for:
  • - Healthy Non-Smoking Males and Females of Non-Childbearing Potential, age 18-55
  • - Body Mass Index between 18-32
  • - Study involves 1 stay of 18 nights, plus 1 additional overnight
  • - Compensation up to $9,324 may be provided for time and participation
  • - Receive up to $500 per qualified participant


Call to schedule a screening appointment.

Part B Cohort 3

Check-In: Dec 6
Check-Out: Dec 24

Check-In: Dec 29
Check-Out: Dec 30

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
Select Measurement System:

Your BMI: result